174 related articles for article (PubMed ID: 19285012)
1. Novel high-throughput screening system for identifying STAT3-SH2 antagonists.
Uehara Y; Mochizuki M; Matsuno K; Haino T; Asai A
Biochem Biophys Res Commun; 2009 Mar; 380(3):627-31. PubMed ID: 19285012
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Based Multiplexed Assay for Identifying SH2 Domain Antagonists.
Asai A; Takakuma K
Methods Mol Biol; 2017; 1555():351-356. PubMed ID: 28092042
[TBL] [Abstract][Full Text] [Related]
3. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
[TBL] [Abstract][Full Text] [Related]
4. Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening.
Hao W; Hu Y; Niu C; Huang X; Chang CP; Gibbons J; Xu J
Bioorg Med Chem Lett; 2008 Sep; 18(18):4988-92. PubMed ID: 18768317
[TBL] [Abstract][Full Text] [Related]
5. Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation.
Park IH; Li C
J Mol Recognit; 2011; 24(2):254-65. PubMed ID: 21360612
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the binding of high affinity phosphopeptides to Stat3.
McMurray JS
Biopolymers; 2008; 90(1):69-79. PubMed ID: 18058821
[TBL] [Abstract][Full Text] [Related]
7. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.
Schust J; Sperl B; Hollis A; Mayer TU; Berg T
Chem Biol; 2006 Nov; 13(11):1235-42. PubMed ID: 17114005
[TBL] [Abstract][Full Text] [Related]
8. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors.
Dourlat J; Valentin B; Liu WQ; Garbay C
Bioorg Med Chem Lett; 2007 Jul; 17(14):3943-6. PubMed ID: 17509878
[TBL] [Abstract][Full Text] [Related]
9. An RNA biding protein, Y14 interacts with and modulates STAT3 activation.
Ohbayashi N; Taira N; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
Biochem Biophys Res Commun; 2008 Aug; 372(3):475-9. PubMed ID: 18503751
[TBL] [Abstract][Full Text] [Related]
10. Novel multiplexed assay for identifying SH2 domain antagonists of STAT family proteins.
Takakuma K; Ogo N; Uehara Y; Takahashi S; Miyoshi N; Asai A
PLoS One; 2013; 8(8):e71646. PubMed ID: 23977103
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
Yu W; Xiao H; Lin J; Li C
J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.
Coleman DR; Ren Z; Mandal PK; Cameron AG; Dyer GA; Muranjan S; Campbell M; Chen X; McMurray JS
J Med Chem; 2005 Oct; 48(21):6661-70. PubMed ID: 16220982
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells.
Anagnostopoulou A; Vultur A; Arulanandam R; Cao J; Turkson J; Jove R; Kim JS; Glenn M; Hamilton AD; Raptis L
Cancer Lett; 2006 Oct; 242(1):120-32. PubMed ID: 16377083
[TBL] [Abstract][Full Text] [Related]
14. A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes.
Zhang X; Yue P; Fletcher S; Zhao W; Gunning PT; Turkson J
Biochem Pharmacol; 2010 May; 79(10):1398-409. PubMed ID: 20067773
[TBL] [Abstract][Full Text] [Related]
15. Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains.
Gunning PT; Katt WP; Glenn M; Siddiquee K; Kim JS; Jove R; Sebti SM; Turkson J; Hamilton AD
Bioorg Med Chem Lett; 2007 Apr; 17(7):1875-8. PubMed ID: 17336521
[TBL] [Abstract][Full Text] [Related]
16. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
Furtek SL; Backos DS; Matheson CJ; Reigan P
ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
[TBL] [Abstract][Full Text] [Related]
17. Nuclear protein IkappaB-zeta inhibits the activity of STAT3.
Wu Z; Zhang X; Yang J; Wu G; Zhang Y; Yuan Y; Jin C; Chang Z; Wang J; Yang X; He F
Biochem Biophys Res Commun; 2009 Sep; 387(2):348-52. PubMed ID: 19595668
[TBL] [Abstract][Full Text] [Related]
18. A new small-molecule Stat3 inhibitor.
McMurray JS
Chem Biol; 2006 Nov; 13(11):1123-4. PubMed ID: 17113993
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters.
Xu J; Cole DC; Chang CP; Ayyad R; Asselin M; Hao W; Gibbons J; Jelinsky SA; Saraf KA; Park K
J Med Chem; 2008 Jul; 51(14):4115-21. PubMed ID: 18578470
[TBL] [Abstract][Full Text] [Related]
20. Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.
Page BD; Khoury H; Laister RC; Fletcher S; Vellozo M; Manzoli A; Yue P; Turkson J; Minden MD; Gunning PT
J Med Chem; 2012 Feb; 55(3):1047-55. PubMed ID: 22148584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
